Plenty of evidence suggests that the accumulation of toxins like soluble amyloid-β (Aβ) and hyperphosphorylated tau cause dysfunction of synaptic plasticity and the simultaneous release of irregular neurotransmitters (NT) at synapses proceed to cognitive decline as seen in Alzheimer’s disease (AD). Here, MAPT is linked to Alzheimer disease.